Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
Live attenuated vaccine: The first clinically approved dengue vaccine?
Katja Fink, Pei Yong Shi
Biochemistry & Molecular Biology
Research output
:
Contribution to journal
›
Review article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Live attenuated vaccine: The first clinically approved dengue vaccine?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Amino Acid
33%
Antivirus Agent
33%
Dengue Vaccine
100%
Dengue Virus
100%
Dengue Virus 1
33%
Disease
33%
Infection
66%
Infectious Agent
33%
Live Vaccine
100%
Immunology and Microbiology
Attenuated Vaccine
100%
Dengue Vaccine
100%
Dengue Virus
100%
Dengue Virus 1
33%
Infectious Agent
33%
Live Vaccine
100%
Serotype
33%
Keyphrases
Amino Acid Content
25%
Dengue Vaccine
100%
Dengue Virus
100%
Disease Symptoms
25%
Human Infection
25%
Live Attenuated Vaccine
100%
Mandatory Vaccines
25%
Mosquito-borne
25%
Tetravalent Vaccine
25%
Viral Pathogens
25%